Glenmark Looks To Chronic Diseases

Possibly encouraged by signs that non-communicable chronic diseases such as diabetes and cancer are on the rise in Africa, Glenmark Pharmaceuticals Nigeria, a subsidiary of India's Glenmark Pharmaceuticals has announced the expansion of its product range. In 2000, almost half the burden of disease was due to non-communicable diseases in low and middle-income countries - a proportion that is set to rise over the coming years as infectious disease control is improved and Western lifestyles become more

To read the full article, please sign in or take a free trial.